These perplexing findings indicate that the intestinal DAMP or PAMP barrier function that is disrupted in inflammasome knockout mice overcomes the anti-inflammatory effect in the liver and TLR4 and TLR9 ligands outflow into the portal vein where they stimulate NASH progression. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.